Ticker
CERSCompany Name
CERUS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -5.98M | -2.77% | $ 216.39M |
3/31/2025 | $ -5.95M | -2.88% | $ 206.78M |
12/31/2024 | $ -7.5M | -3.72% | $ 201.32M |
9/30/2024 | $ -5.66M | -2.86% | $ 197.91M |
6/30/2024 | $ -9.82M | -5.05% | $ 194.51M |
3/31/2024 | $ -17.2M | -8.97% | $ 191.72M |
12/31/2023 | $ -23.87M | -12.78% | $ 186.8M |
9/30/2023 | $ -36.7M | -19.86% | $ 184.78M |
6/30/2023 | $ -39.03M | -21.23% | $ 183.87M |
3/31/2023 | $ -35.16M | -19.13% | $ 183.77M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for CERUS CORP is calculated as follows: EBITDA [ $ -54.13M ] / Revenues [ $ 107.15M ]
(=) EBITDA % [ -50.52% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |